HBV Cure Pipeline
Defining and Striving for HBV Cure: What’s in the Pipeline

Released: June 30, 2022

Expiration: June 29, 2023

Carla Coffin
Carla Coffin, MD

Activity

Progress
1
Course Completed
In this episode, Carla S. Coffin, MD, MSc, shares her thoughts on the different investigational approaches under evaluation for their potential to achieve HBV cure, including entry inhibitors, capsid inhibitors, siRNAs, immune modulators, TLR agonists, therapeutic vaccines, and checkpoint inhibitors.